Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial
scientific article published on 20 September 2019
Author/s
author: Christian Herder, Stefan Kopf, Oliver Kuss, Norbert Stefan, Andreas Birkenfeld, Michael Roden, Jürgen Machann, Konstantinos Kantartzis, Merit Lagerpusch, Andreas Pfeiffer, Birgit Knebel, Daniel F Markgraf
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.